We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Retinal Toxicity and the Use of Hydroxychloroquine and Chloroquine in the Current Management of COVID-19: An Updated Advisory for Ophthalmologists and Other Health Care Professionals (March 28, 2020).
- Authors
Aguilar, Romulo N.; Silva, Paolo Antonio S.; Salongcay, Recivall P.; Arcinue, Cheryl A.; Cruz, Franz Marie; Go, Rory King
- Abstract
However, this is now less frequently encountered as current retinal imaging and diagnostic techniques in the current screening Chloroquine (CQ) and hydroxychloroquine (HCQ) are drugs that have been recommended for compassionate use in patients with moderate to severe COVID-19 infection. • Visual symptoms developing among COVID-19 patients under HCQ or CQ treatment should not prevent the continuation of an HCQ or CQ regimen. Presently, there is no data on the risk of retinal toxicity among patients on short course, high dose HCQ or CQ therapy such as that presently recommended for the treatment of COVID-19 patients.
- Subjects
MEDICAL personnel; COVID-19; HYDROXYCHLOROQUINE; CHLOROQUINE; OPHTHALMOLOGISTS
- Publication
Philippine Journal of Ophthalmology, 2020, Vol 45, Issue 2, p6
- ISSN
0031-7659
- Publication type
Article